Purcell & Lefkowitz LLP is investigating Celldex Therapeutics on behalf of shareholders to determine if the company's directors breached their fiduciary duties related to recent corporate actions. Shareholders interested in their rights can contact the law firm for more information and legal support. This investigation could impact shareholder confidence and the company's governance practices.
The shareholder investigation of Celldex Therapeutics is the subject here, with Pluang's health sector data providing context. For readers following health stocks, 64 of 128 priced US health-sector stocks rose while 43 fell. Notable movers include CTXR at USD 0.49 with a -1.86% change and a typical hold time of 17 days, XRAY at USD 8.67 with a -1.81% change and a hold time of 72 days, and DNA at USD 12.79 with a -1.62% change and a hold time of 7 days. These figures are as of Oct 12, 2026 18:51 WIB.
The global AI accelerator market is projected to grow from $151 billion in 2025 to $443 billion by 2030, with a compound annual growth rate of about 24%. This expansion is fueled by the rise of generative AI, large language models, and increased inve...
A growing town replaced its inefficient IT request process of spreadsheets and emails with a centralized Microsoft Power Apps hub developed by eSoftware Associates. This hub integrates project intake, risk assessment, and PMO scoring into one platfor...
No7 Software has enhanced its Anchor Loyalty & Rewards app by integrating Shopify POS, allowing merchants to run a unified loyalty program across online stores and physical shops. Customers now maintain a single points balance, tier status, and refer...
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
